Search

Your search keyword '"THROMBOEMBOLISM risk factors"' showing total 1,052 results

Search Constraints

Start Over You searched for: Descriptor "THROMBOEMBOLISM risk factors" Remove constraint Descriptor: "THROMBOEMBOLISM risk factors" Search Limiters Full Text Remove constraint Search Limiters: Full Text
1,052 results on '"THROMBOEMBOLISM risk factors"'

Search Results

1. Time Relationship between the Occurrence of a Thromboembolic Event and the Diagnosis of Hematological Malignancies.

2. External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer.

3. Thrombotic Complications in Pediatric Cancer.

4. Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods.

5. Prevention of venous thrombosis through intraoperative intermittent pneumatic compression (IPC): a best practice implementation project.

6. Impact of COVID‐19 infection among patients hospitalized for conventional pacemaker implantation: Analysis of the Nationwide Inpatient Sample (NIS) 2020.

7. One‐year outcomes of rate versus rhythm control of atrial fibrillation in the Kerala‐AF Registry.

8. Independent Risk Factors Associated With Venous Thromboembolism After Knee Arthroscopy: A Retrospective Study of 222 Patients.

9. Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP).

10. Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study.

11. Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis.

12. Mycoplasma pneumoniae pneumonia-associated thromboembolism with plastic bronchitis: a series of five case reports and literature review.

13. Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines.

14. Ischemic stroke associated with high-grade pedunculated device-related thrombosis following left atrial appendage closure.

15. The Outcomes for Different Biological Heart Valve Prostheses in Surgical Aortic Valve Replacement before and after the Introduction of Transcatheter Aortic Valve Implantation.

16. Double bad luck: pulmonary embolism and vaginal bleeding - a case report.

17. Successful ECMO treatment in patients with cerebral hemorrhage and PROC gene mutation associated with VTE: a case report.

18. Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE.

19. Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study.

20. Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation.

21. European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism.

22. Risk factors for venous thromboembolism in a single pediatric intensive care unit in China.

23. The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients.

24. Impact of Earthquakes on Lung Health.

25. Short-Term Outcomes of Conventional Laparoscopic versus Robot-Assisted Distal Pancreatectomy for Malignancy: Evidence from US National Inpatient Sample, 2005–2018.

26. Incidence and influence factors of venous thromboembolism in traumatic rib fracture patient: a multicenter study.

27. Superficial Venous Thrombosis: A Comprehensive Review.

28. A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer.

29. Nomogram for hospital-acquired venous thromboembolism among patients with cardiovascular diseases.

30. Novel Insights in Venous Thromboembolism Risk Assessment Methods in Ambulatory Cancer Patients: From the Guidelines to Clinical Practice.

31. Relationship between Brain Natriuretic Peptide and Thromboembolic Events in Elderly Patients with Nonvalvular Atrial Fibrillation.

32. The Risk of Left Atrial Appendage Thrombus in Patients With Atrial Flutter Versus Atrial Fibrillation.

33. Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.

34. Cerebral Venous Thrombosis in Pregnant and Postpartum Women Presenting to the Emergency Department with Headaches.

35. Comparison of Early Complication Rates After High Tibial Osteotomy Versus Unicompartmental Knee Arthroplasty for Knee Osteoarthritis.

36. Cancer-Associated Thrombosis: Epidemiology, Pathophysiological Mechanisms, Treatment, and Risk Assessment.

37. Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study.

38. Factors associated with venous thromboembolic disease due to failed thromboprophylaxis.

39. Risk factors of multiple pulmonary emboli in an elite Ironman triathlete: a case report.

40. Direct Oral Anticoagulants in Nephrotic Syndrome: Our Experience and Literature Review.

41. Delayed surgery after hip fracture affects the incidence of venous thromboembolism.

42. Development and Validation of a Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery: A 6-Year, Multicenter, Retrospective and Prospective Diagnostic Cohort Study.

43. The Role of Anticoagulation in Tumor Thrombus Associated with Renal Cell Carcinoma: A Literature Review.

44. Incidence and Risk Factors Associated with Thromboembolic Events among Patients with COVID-19 Inpatients: A Retrospective Study.

45. Cancer-Associated Abdominal Vein Thrombosis.

46. Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.

47. Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study.

48. A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19.

49. Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis.

50. Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.

Catalog

Books, media, physical & digital resources